Ensign Peak Advisors
CDNA icon

Ensign Peak Advisors’s CareDx CDNA Stock Holding History

Ensign Peak Advisors’s Portfolio CDNA Stock Details CDNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-10,810
Closed -$184K – 1862
2022
Q3 		$184K Hold
10,810
– – ﹤0.01% 1906
2022
Q2 		$232K Hold
10,810
– – ﹤0.01% 1747
2022
Q1 		$400K Hold
10,810
– – ﹤0.01% 1650
2021
Q4 		$492K Buy
+10,810
New +$564K ﹤0.01% 1635
2021
Q2 		– Sell
-19,313
Closed -$1.31M – 1832
2021
Q1 		$1.31M Sell
19,313
-16,870
-47% -$1.31M ﹤0.01% 1309
2020
Q4 		$2.62M Buy
36,183
+8,709
+32% +$505K 0.01% 908
2020
Q3 		$1.04M Buy
+27,474
New +$928K ﹤0.01% 1296
2020
Q1 		– Sell
-1,000
Closed -$22K – 1633
2019
Q4 		$22K Buy
+1,000
New +$22.9K ﹤0.01% 1659

Other funds holding CDNA

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return
GS
Gagnon Securities New York $433M AUM 29.08% 1-Year Est. Return

Ensign Peak Advisors's CDNA Position: Q4 2022 in Review

Ensign Peak Advisors sold out of CareDx (CDNA) in Q4 2022, closing a stake of 10,810 shares — an estimated $184K sold.

Ensign Peak Advisors first reported a position in CDNA in Q4 2019 and held it in 8 quarters. The position peaked at $2.62M in Q4 2020. 168 funds tracked by Wall St. Rank hold CDNA as of Q4 2022.

  • Ensign Peak Advisors reported no remaining CareDx position as of Q4 2022 after selling out during the quarter.
  • Ensign Peak Advisors sold 10,810 CareDx shares in Q4 2022, an estimated $184K.
  • Ensign Peak Advisors first reported a position in CareDx in Q4 2019 and held it in 8 quarters.
  • Ensign Peak Advisors's CareDx position peaked at $2.62M in Q4 2020.
  • 168 funds tracked by Wall St. Rank held CareDx as of Q4 2022.

Based on Ensign Peak Advisors's 13F filing for Q4 2022, filed 13 Feb 2023.